Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives-Reference-Cited by-同舟云学术

Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives

Published:2021-02-05 Issue:1 Volume:39 Page:196-202
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Benucci Maurizio¹,Infantino Maria²,Marotto Daniela³,Ardizzone Sandro⁴,Manfredi Mariangela²,Sarzi-Puttini Piercarlo⁵

Affiliation:

1. Rheumatology Unit, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy.

2. Immunology and Allergology Laboratory, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy.

3. Rheumatology Unit, P. Dettori Hospital, AST Sardegna, Tempio Pausania, Italy.

4. Gastroenterology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan University School of Medicine, Milan, Italy.

5. Rheumatology Unit, Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Milan University School of Medicine, Milan, Italy. piercarlo.sarziputtini@gmail.com

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Exacerbation of Rheumatic Disease after COVID-19 Vaccination;Journal of Clinical Rheumatology and Immunology;2023-02-17

2. Factors influencing the course of COVID-19 in the inflammatory rheumatic diseases;Clinical and Experimental Rheumatology;2022-08-10

3. Reactivation of adult-onset Still’s disease after use of the COVID-19 ChAdOx1-S vaccine;BMJ Case Reports;2022-08

4. Immunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE;Clinical and Experimental Rheumatology;2022-04-07

5. Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs;Clinical and Experimental Rheumatology;2022-01-15